Premium
PROGRAMMED CELL DEATH‐LIGAND 1 EXPRESSION AND IMMUNOSCORE IN STAGE II AND III NON‐SMALL CELL LUNG CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_73
Subject(s) - medicine , adjuvant chemotherapy , stage (stratigraphy) , oncology , lung cancer , citation , chemotherapy , adjuvant , cancer , ligand (biochemistry) , library science , receptor , paleontology , breast cancer , computer science , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom